RASP must carefully review the terms and conditions of MTAs for incoming materials so as not to compromise the institution's academic principles, obligations to funding sponsors, or its financial health.
Please note: It is the responsibility of the WMC investigator to keep track of his/her obligations with regard to materials exchanged via MTAs. In particular, the P.I. must be mindful of restrictions on use of the materials received from third parties, pre-publication review rights of the material providers and rights in new inventions.
Material Transfer to and from Not-For-Profit Institutions/Academic Institutions
The National Institutes of Health and the Association of University Technology Managers (AUTM) developed standard language to simplify material transfers, issued as the Uniform Biological Material Transfer Agreement (UBMTA). The UBMTA is used for many transfers between academic institutions. The UBMTA includes two sample letters: the Implementing Letter Agreement and the Simple Letter Agreement. The first is used for transfer of materials that are the subject of a patent or patent application or that has been or is likely to be commercially licensed. The Simple Letter Agreement is used for all other transfers.
MTA - Implementing Letter Agreement
word document
|
adobe pdf
MTA - Simple Letter Agreement
word document
|
adobe pdf
Material Transfer to and from Industry
Material Transfer from Industry to WMC
Generally an agreement is provided by industry for the transfer of materials from Industry to WMC. Each industrial MTA is different and must be negotiated separately on a case-by-case basis, depending on the terms used in the agreement, the Investigator's obligations to the sponsor(s) of the research, and the use the investigator plans for the material.
When industry is sending WMC Material, please obtain:
- an electronic version of the MTA
- a hard copy of the MTA
- MTA routing form (see below)
- contact information for both Investigator and industry
Material Transfer from WMC to Industry
WMC Center for Technology, Enterprise and Commercialization manages MTAs that are outgoing to industry. For further information about technology transfer at WMC, please see the Office of Technology Development section of this web site.
Procedure for the Transfer of Material
Prior to transferring Materials, WMC Investigators should sign the appropriate MTA, mail the form to the Recipient Investigator and have the Investigator obtain all required signatures. Recipient organization should mail the MTA for execution to:
Juan Torres, JD
MTA Manager
Weill Medical College of Cornell University
Research & Sponsored Programs
1300 York Avenue
Box 89
New York, NY 10021
For expediency, faxed signatures from recipients are acceptable, followed by an original. Recipient should send fax form to 212-821-0799, Attn: Juan Torres, Grants & Contracts Department.
MTA Routing Form
An MTA Routing Form facilitates the transfer of various kinds of materials - biological materials, compounds, equipment, and prototypes - for use in research projects. The MTA Routing Form informs the department through Laboratory Head Chair and the Associate Dean's office of the kind of materials to be received and the nature of their application. It also ensures that the proposed research will be reviewed for consistency with institutional policies and obligations.
Principal Investigator's Responsibilities. An MTA Routing Form is required and must be completed and submitted with an agreement for the processing of any material being transferred in or out of the Institution. Please ensure that all fields are completed accurately. An incomplete form will significantly delay the process of your MTA. Please note that the routing form must be signed by Laboratory Head and PI. The MTA Routing Form should not be signed by students of postdoctoral researchers or fellows. A brief description of the materials and their intended use should be attached to the MTARF. This information assists in determining any contractual conditions that need to be modified or removed and University exposure to liabilities.
Faculty or departmental administrators do not have the authority to accept these agreements on behalf of the University. Accepting such agreements without an Authorized University signature may result in the assumption of unnecessary personal liability.
| |
Download the MTA Sending Routing Form (to accompany MTAs; for sending material from WMC) |
|
Download the MTA Receiving Routing Form (to accompany MTAs; for receipt of material by WMC) |
Please note: In an effort to maintain accurate records, all future executed MTAs must be forwarded to RASP. If you have received a fully executed agreement in the past, please forward the original (preferred) or copy to RASP. All paperwork can be sent to the attention of Juan Torres via one of the following: inter-office mail Box 89, drop off in A-128 or fax (212) 821-0799.
Tri Institutional MTA
Tri-Institutional hESC-related Material Transfer Agreement will be a Master MTA to govern the transfer of human embryonic stem cell (hesc) lines between the Tri-Institutions (Memorial-Sloan Kettering Cancer Center, The Rockefeller University and Joan & Sanford I. Weill Medical College of Cornell University). Each institution (and PI) would then fill out the Implementing Letter/Routing Form that will accompany the actual transfer of each hesc lines.
Download the Tri Institutional MTA FormSelect Agents
To determine whether or not the use of material involve select agents, refer to http://www.cdc.gov/od/sap or contact Environmental Health and Safety (EHS) at (212) 746-6201 for assistance in determining select agent status of biological materials.
If yes, the permitting and shipment of materials must be coordinated by the Office of Environmental Health and Safety. All materials must be permitted by the Centers for Disease Control and Prevention prior to their receipt/shipment. To ship/receive a select agent, WMC must have a permit for the material, the shipment/receipt must be approved by CDC, and the shipment must be shipped/received by EHS.
